Delivery Order SPE2DB22D1017-SPE2DB25FF7RJ
Award Date
3/13/25
Potential Completion Date
3/14/25
Potential Value
$7.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,572.03 delivery order contract is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 mL, a medication used for diabetes management. The contract has a completion date of February 19, 2025 and is a firm fixed-price contract. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,320.29, is for the delivery of Ozempic 0.25-0.5 mg/dose pen 3 mL, a medication used for diabetes management. The contract is a firm fixed-price delivery order with a completion date of November 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $62,628.10, is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 ml, a medication used for the treatment of diabetes. The contract is a firm fixed-price delivery order with a completion date of February 10, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $5,826.15 and is for the delivery of Ozempic 0.25-0.5 mg/dose pen 3 mL, a medication used for diabetes management. The contract has a firm fixed price pricing type and a completion date of November 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,563.97 firm fixed-price delivery order is for Ozempic 0.25-0.5 mg/dose pen 3mL, a medication used to manage diabetes. The contract has an ultimate completion date of January 9, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,119.60, is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 ml, a medication used for the treatment of diabetes. The contract has an ultimate completion date of November 22, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,407.96 firm fixed-price contract is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 mL, a medication used to treat diabetes. The contract has a completion date of November 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 mL, a medication used for diabetes management. The contract has a firm fixed price of $6,176.79 and a completion date of January 27, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,154.74, is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a medication used to manage diabetes. The contract is a firm fixed-price arrangement with a period of performance through March 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,322.16, is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a period of performance through November 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between...